The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ibl-international.com

Stage

Acquired | Acquired

Valuation

$0000 

About IBL International

IBL International employs staff of over 80 and has its main operations located in Hamburg, Germany. The company develops, manufactures and offers a comprehensive portfolio of ELISAs, RIAs and luminescence immunoassays for life science research and routine clinical diagnosis, including a large selection of specialty assays for endocrinology, neurodegeneration, neonatal screening, and assessing steroid hormones in saliva. IBL International has dedicated sales teams in Germany, North America and the Benelux as well as an extensive distributor network.

IBL International Headquarter Location

194 Wildcat Road

Toronto, Ontario, M3J 2N5,

Canada

866-645-6755

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing IBL International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IBL International is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

H

Health IT

7,900 items

Latest IBL International News

Haptoglobin Reagent Market 2029 Size, Industry Share, Growth, Trends and Top Key Players: SDIX, LLC, Lab Mark A.s., Abbott Laboratories, IBL International (Tecan Group Ltd.), Analytik Jena AG, and Others.

Jul 1, 2021

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Haptoglobin Reagent Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which...

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.